Finance & Economy

  • Gulf Oil Records Highest-Ever Quarterly Volume, Revenue and EBITDA;

    Gulf Oil Records Highest-Ever Quarterly Volume, Revenue and EBITDA;

    Achieved Double-Digit Volume Growth Bengaluru : Gulf Oil Lubricants India Limited, a Hinduja Group Company, has today reported its unaudited financial results (Standalone and Consolidated) for the Quarter ended June 30, 2025. Key highlights are as…

  • Muthoot FinCorp standalone Q1 revenue up by 26.47% in Q1 FY26

    Muthoot FinCorp standalone Q1 revenue up by 26.47% in Q1 FY26

    Bengaluru : Muthoot FinCorp Limited, the flagship company of the 138-year-old Muthoot Pappachan Group (Muthoot Blue), announced robust consolidated financial results for the first quarter of FY26. The Company reported Q1 standalone revenue for the…

  • Dhruv Consultancy Secures Achieves Strong 82% Cons. Net Profit Growth in Q1 FY26

    Dhruv Consultancy Secures Achieves Strong 82% Cons. Net Profit Growth in Q1 FY26

    Mumbai : Dhruv Consultancy Services Limited. (DCSL) (BSE – 541302 | NSE – DHRUV), one of the leading infrastructure consultancy companies in India, has announced its unaudited financial results for the Q1 FY26. Key Consolidated Financial Highlights- Revenue of ₹ 21.40 Cr, YoY growth of…

  • Regaal Resources IPO subscribed 159.88 times on Final Day

    Regaal Resources IPO subscribed 159.88 times on Final Day

    The Initial Public Offering of Regaal Resources Limited was subscribed 159.88 times on the final day of bidding. The issue received bids of 3,35,73,63,312 shares against the offered 2,09,99,664 equity shares, at a price band of ₹96-102, according to the data…

  • Studio LSD Limited to Raise ₹74.25 Cr via IPO Opening August 18, 2025

    Studio LSD Limited to Raise ₹74.25 Cr via IPO Opening August 18, 2025

    Mumbai : Studio LSD Limited (Studio LSD, The Company) is a multimedia production house specializing in creating original and captivating content, proposes to open its Initial Public Offering on Aug 18th, 2025, aiming to raise ₹ 74.25 Crores (at…

  • Supriya Lifescience Ltd. Reports Rs 145.07 Cr Revenue and 35.6% EBITDA Margin in Q1 FY26

    Supriya Lifescience Ltd. Reports Rs 145.07 Cr Revenue and 35.6% EBITDA Margin in Q1 FY26

    Mumbai : The unaudited financial statements for the Q1FY26 results have been released by Supriya Lifescience Ltd., a cGMP-compliant business with a strong track record in API manufacturing and a focus on products from a variety…